Learning Objectives

It is expected that the 2019 ESC Guidelines on Dyslipidaemias will change the prevention landscape being more aggressive in LDL reduction for high-risk groups. It is important to focus and educate cardiologists on this very important prevention chapter

Key opinion leaders will discuss:

Grey zones of prevention. Which patients show enhanced risk?
How low is very low concerning LDL?
When to add ezetimibe?
When to add PCSK9?
This webinar shall educate and provide the cardiologist with all the up-to-date knowledge on the 2019 ESC Guidelines on Dyslipidaemias.

After this webinar physicians should be able to:

Identify patient populations for the new targets;
Learn the rationale behind these targets; and
Feel more confident about hypolipidemic drugs safety.

ESC 365 is supported by